Prevalence of active hepatitis c virus infection in district mansehra pakistan by Ali, Amjad et al.
RESEARCH Open Access
Prevalence of active hepatitis c virus infection in
district mansehra pakistan
Amjad Ali
1, Habib Ahmad
2*, Ijaz Ali
3, Sheema Khan
4, Gulshan Zaidi
5, Muhammad Idrees
5
Abstract
Prevalence of active hepatitis C virus (HCV) infection in apparently healthy inhabitants of District Mansehra, Pakistan
was surveyed during September, 2009 to May, 2010. Subjects of different age and gender groups were analyzed
through random blood sampling from people of three areas viz; Tehsil Mansehra, Tehsil Balakot and Tehsil Oghi.
Sum of 400 individuals, 300 male and 100 females with age groups from 10 years to 50 and above were included
in the study. All the individuals were screened for antibodies against HCV. The positive samples thus screened,
were subjected to polymerase chain reaction (PCR) analysis for detection of HCV-RNA. The results showed that
3.5% of the people of District Mansehra are actively infected with HCV whereas 7% of the population in general,
has the presence of antibodies against HCV in their blood. It was also concluded that the prevalence of active HCV
infection was high 4% in males as compared to females (2%). The prevalence of HCV proportionality increases with
the increase in age of the people. Its incidence was highest (7.69%) in the people of the age group of 51 years
and above, whereas no sign of infection was recorded for the age group of 10-20 years.
1. Background
H u m a nh e p a t i t i sCi sa ni n f e c t i o u sd i s e a s ea f f e c t i n gt h e
liver, caused by the Hepatitis C Virus (HCV). The infec-
tion is often asymptomatic, but once established, it can
progress to the fibrosis of liver and ultimately cirrhosis.
In some cases, those with cirrhosis will go on to develop
liver failure and other complications including liver can-
cer [1]. HCV is the only known member of the Hepaci-
virus genus in the family Flaviviridae.I ti ss i n g l e
stranded 50 nm positive sense RNA virus with six major
genotypes causing hepatitis C in the whole of the world
[2,3]. It is reported that approximately 15-40% of per-
sons infected with HCV clear the virus from their
bodies during the acute phase of infection and the
remaining 60-85% of patients infected with HCV devel-
ops chronic hepatitis C [4], which progresses to liver
cirrhosis with an elevated risk of the development of
hepatocellular carcinoma [2,5,6].
There are about 170 million patients with HCV in the
world and three to four million individuals are diag-
nosed as new cases every year [7,8]. Pakistan, a develop-
ing nation of 170 million people has alarmingly rate of
outbreaks of hepatitis C virus [9-12] which need proper
survey and genotyping. Seroprevalenc studies of anti-
HCV antibodies in the general population of Pakistan
have been recorded as 5.31% to 7.5% [13-15]. HCV pre-
valence is in the range of 4.1 to 36% reported from var-
ious parts of Khyber Pukhtoonkhwa Province of
Pakistan [16,17] but no data has been reported till now
on the prevalence of HCV from District Mansehra.
Majority of the studies conducted have focused on the
prevalence of anti-HCV antibodies which is least infor-
mative about the active HCV infection. PCR has
emerged as a powerful molecular diagnostic tool for the
detection of active infection which is manifested by the
presence of HCV RNA in the blood of the infected per-
son. As no study has earlier been conducted to figure
out the prevalence of anti-HCV antibodies or HCV
RNA among the general population of District Man-
sehra, we for the first time conducted our study to find
out prevalence of active HCV infection in general popu-
lation of District Mansehra.
2. Methods
Blood Sampling
The study included individuals from all over Mansehra
District of Khyber Pakhtunkhwa province. Informed
consent was taken from individuals under observation.
A total of 400 apparently healthy individuals comprised
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were included in the study. History of volunteers was
recorded in the form of questionnaires.
Random blood sampling was done from the three
Tehsils of District Mansehra, namely Tehsil Mansehra,
Tehsil Balakot and Tehsil Oghi. From every volunteer 5
ml of blood was collected in separate disposable sterile
syringes. Blood was transported to Institute of Biotech-
nology & Genetic Engineering (IBGE), Peshawar where
it was centrifuged for 5 minutes at 15000 rpm to sepa-
rate serum.
Immuno-chromatographic tests (ICT)
Sera screening was done for anti-HCV antibodies with
the help of Immuno-chromatographic tests by using
strips from (Accurate, USA) followed by (Acon, USA).
The positive samples were subjected to further analysis.
RNA Extraction and PCR
HCV RNA was extracted from 200 μls e r u ms a m p l eb y
using Ana-gen RNA extraction kit (Ana-gen, USA)
according to manufactures’ instructions. cDNA was pre-
pared by Reverse transcription PCR using M-MLV
reverse transcriptase (Fermentas, USA). The amplified
cDNA was further subjected to two rounds of PCR
amplifications using nested primers [18]. The conditions
for the first round PCR were as follows; An initial dena-
turation step at 95°C for 2 minutes followed by 30
cycles of 94°C for 45 seconds, 54°C for 45 seconds, and
72°C for 1 minute performed in a thermal cycler
(Eppendorf, Germany). The conditions for the 2nd
r o u n dP C Rw e r et h es a m ee x c e p tt h a tad i f f e r e n ts e to f
inner primers was used and the annealing temperature
was raised to 62°C in order to amplify the 1st round
product.
Gel Electrophoresis and Documentation
All the PCR products (first and second rounds) were
analyzed on 1.8% agarose gel prepared in 0.5% TBE buf-
fer, stained with ethedium bromide (10 mg/ml) as flor-
escent dye. Gels were photographed using Alpha quant
(Alpha Innotech). A 100-bp DNA ladder (Gibco BRL)
was used as DNA size marker.
Statistical Analysis
SPSS version 14.0 for windows was used for the statisti-
cal analysis of the data. The results were obtained in
rates (%).
3. Results
A total of 400 apparently healthy individuals were ran-
domly sampled for the study. Theses individuals
belonged to various Tehsils of District Mansehra namely
Tehsil Mansehra, Tehsil Balakot and Tehsil Oghi. Out
of the total 400 samples examined, 300 were males
while 100 samples were from the female population
(table 1).
All the individuals were categorized into five age
groups. Sera were isolated from all the blood samples
and subsequently tested for anti-HCV antibodies by
Immuno Chromatographic test (ICT). The samples were
first tested using ICT strips from Accurate (USA), fol-
lowed by ICT strips from Acon (USA). The results indi-
cated that 28 out of 400 individuals had anti-HCV
antibodies in their blood. These individuals belonged to
various age groups (Table 2). As anti-HCV antibodies
are not informative about the active HCV infection
therefore all the anti-HCV positive samples were pro-
cessed for RNA extraction and RT PCR.
Anti- HCV positive samples were subjected to PCR.
The PCR results revealed that 14 (3.5%) individuals had
active HCV infection as indicated by the detection of
HCV RNA in their blood (Figure 1).
The prevalence of anti-HCV antibodies and HCV
RNA in the case of male and female population as
determined by the combination of Immuno Chromato-
graphy procedures and PCR is given in Table 3. Over all
result revealed that active HCV infection in District
Manehra is 3.5% (Figure 2).
4. Discussion
Hepatitis C is rapidly emerging as a major health pro-
blem in developing countries including Pakistan [19,20].
The World Health Organization estimates that approxi-
mately 3% of the world populations has been infected
Table 1 Basic information about the blood samples
collected from District Mansehra
Tehsil No. of samples Male Female
Mansehra 170 120 50
Balakot 130 98 act 32
Oghi 100 82 18
Total 400 300 100
Table 2 Age wise distribution of the anti- HCV antibodies
and HCV RNA
Age group No. of samples Anti-HCV +ve HCV RNA +ve
10-20 years 48 0 (0%) 0 (0%)
21-30 years 110 4 (3.64%) 2 (1.82%)
31-40 years 94 6 (6.38%) 2 (2.13%)
41-50 years 70 10 (14.28%) 4 (5.71%)
51 and above 78 8 (10.26%) 6 (7.69%)
Total 400 28 (7%) 14 (3.5%)
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patients with HCV in the world and three to four mil-
lion individuals are diagnosed as new cases every year
[22,23].
Prevalence of HCV may be different in different
regions and various groups of the same community [24].
Hospital-based studies revealed prevalence rates of HCV
as 5.31% in Islamabad [25], 2.45% -20.89% in various
parts of the Punjab province [26-28], 4-6% in Karachi
[29], 5%-9% in North West Frontier Province (N-W.F.P)
[30,31] and 25.7% in Northern Areas [32]. Slightly
higher prevalence of HCV was recorded in the earth
quake affected areas of Pakistan in 2005 [20].
For the investigation of the active HCV infection we
relied on the highly sensitive method of detection that is
Polymerase Chain Reaction. We collected 400 hundred
samples from the general apparently healthy male and
female populations of the District Mansehra, Pakistan
and subjected them to ICT and PCR. 3.5% individuals
turned out to be actively infected with HCV. Anti-HCV
antibodies were found in 7% of individuals. Higher per-
centage prevalence of anti-HCV antibodies could be
attributed to the false positive results as are experienced
during Immuno- Chromatographic strip Tests or the
self limiting nature of the HCV infection.
The study revealed that young people of district Man-
s e h r a( i nt h ea g eg r o u p so f1 0 - 2 0y e a r s )h a v en oa c t i v e
HCV infection. The absence of HCV infection in this
age group may be due to their least exposure to some of
the high risk factors causing HCV such as exposure to
barbers etc. The highest active HCV infection was 7.69%
observed in age group 51-60. These people had variable
history of exposure to HCV risk factors such as major/
dental surgery or blood transfusion. Second highest
active HCV infection was 5.71% observed in age group
41-50. Our study is partially in agreement with one
s t u d y[ 3 1 ] ,w h i c hw a sc o n d u c t e do nt h ep r e v a l e n c eo f
HCV in relation to age groups and observed that High
prevalence of HCV was among middle-aged (40-50
years) people. Third highest active HCV infection was
2.13% observed in age group 31-40 years. People includ-
ing in age group 21-30 years revealed 1.82% active HCV
infection. High prevalence of HCV infection in male
population has earlier been recorded by other studies
from Pakistan and around the globe. The prevalence of
HCV in different age groups of both sexes was studied
and it was found that the prevalence of HCV was maxi-
mum (8.92%) in mature males as compared to young
males (6.66%) [33]. Our study is in agreement with the
fact that male population is more affected by HCV as is
indicated by HCV prevalence of 4% in the male popula-
tion of District Mansehra. The female population is
least affected with 2% active prevalence as compared to
male population of District Mansehra. High prevalence
in male and lower prevalence in female again could be
attributed to their exposure status to various HCV risk
factors which was quite evident from the life style and
history of the individuals sampled for this study. Over
all our study reveals that 7% of the population of district
Mansehra have antibodies against HCV in their blood
while 3.5% people are actively infected with HCV.
Conclusion
The prevalence of active HCV recorded in different age
and gender groups show that its frequency has increased
with the increase in age. Children whether males or
females were the least infected whereas its prevalence
was highest in the age group of 51 years and above.
Furthermore the rate of infection in female population
was almost 50% as compared to males. The least inci-
dence of HCV in females could be attributed to low
exposure to HCV risk factors due to male dominating
society of the area and also the estrogen hormone in
females is considered to play a role in the spontaneous
clearance of HCV infection [34].
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Figure 1 Typical gel photograph of HCV amplified products.
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Table 3 Sex- wise distribution of the anti- HCV antibodies
and HCV RNA
Sex Total No. of samples Anti-HCV +ve HCV RNA +ve
Male 300 22 (7.33%) 12 (4%)
Female 100 6 (6%) 2 (2%)
Total 400 28 (7%) 14 (3.5%)
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